نتایج جستجو برای: thrombocythemia

تعداد نتایج: 1972  

Journal: :Blood 2012
Peter J Campbell Cathy MacLean Philip A Beer Georgina Buck Keith Wheatley Jean-Jacques Kiladjian Cecily Forsyth Claire N Harrison Anthony R Green

Essential thrombocythemia, a myeloproliferative neoplasm, is associated with increased platelet count and risk of thrombosis or hemorrhage. Cytoreductive therapy aims to normalize platelet counts despite there being only a minimal association between platelet count and complication rates. Evidence is increasing for a correlation between WBC count and thrombosis, but prospective data are lacking...

2014
Krisstina Gowin Ruben Mesa Ann Mullally Laura C. Michaelis

Essential thrombocythemia is a clonal myeloproliferative neoplasm characterized by an elevated platelet count, the potential for both microvascular and macrovascular sequelae, and a risk for transformation to myelofibrosis or acute myeloid leukemia. A systematic and detailed initial analysis is essential for accurate diagnosis of essential thrombocythemia, as many etiologies are reactive and be...

Journal: :Hematology. American Society of Hematology. Education Program 2011
Francisco Cervantes

Essential thrombocythemia (ET) is a Philadelphia chromosome (Ph)-negative myeloproliferative neoplasm (MPN) characterized by thrombocytosis and megakaryocytic hyperplasia of the bone marrow, with presence of the JAK2 V617F mutation in 50%-60% of patients. ET evolves to myelofibrosis in a minority of cases, whereas transformation to acute leukemia is rare and increases in association with the us...

Journal: :Advances in Dermatology and Allergology 2014

Journal: :Journal of Veterinary Internal Medicine 1990

Journal: :The New England journal of medicine 2005
Claire N Harrison Peter J Campbell Georgina Buck Keith Wheatley Clare L East David Bareford Bridget S Wilkins Jon D van der Walt John T Reilly Andrew P Grigg Paul Revell Barrie E Woodcock Anthony R Green

BACKGROUND We conducted a randomized comparison of hydroxyurea with anagrelide in the treatment of essential thrombocythemia. METHODS A total of 809 patients with essential thrombocythemia who were at high risk for vascular events received low-dose aspirin plus either anagrelide or hydroxyurea. The composite primary end point was the actuarial risk of arterial thrombosis (myocardial infarctio...

Journal: :Haematologica 2012
Thomas Buhr Konnie Hebeda Vassiliki Kaloutsi Anna Porwit Jon Van der Walt Hans Kreipe

BACKGROUND The World Health Organization classification of myeloproliferative neoplasms discriminates between essential thrombocythemia and the prefibrotic phase of primary myelofibrosis. This discrimination is clinically relevant because essential thrombocythemia is associated with a favorable prognosis whereas patients with primary myelofibrosis have a higher risk of progression to myelofibro...

Journal: :Stroke 1985
T Delangre B Mihout J Y Borh M Samson

A patient suffering from essential thrombocythemia presented manifestations of digital thromboses and two cerebral ischemic strokes. Anomalies of platelet function are discussed in relation to published data and the efficacy of antiaggregant treatment is stressed.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید